Global Cell Therapy Market – Industry Trends and Forecast to 2030

Global Cell Therapy Market, By Technology (Somatic Cell Technology, Cell Immortalization Technology, Viral Vector Technology, Genome Editing Technology, Cell Plasticity Technology, Three-Dimensional Technology), Type (Autologous, Allogeneic), Cell Type (Stem Cell and Non-Stem Cell), Cell Source (iPSCs, Bone Marrow, Umbilical Cord Blood-Derived Cells, Adipose Tissues, Neural Stem Cell), Application (Musculoskeletal, Cardiovascular, Gastrointestinal, Neurological, Oncology, Dermatology, Wounds & Injuries, Ocular, Others), End-User (Hospitals & Clinics, Regenerative Medicine Centres, Diagnostic & Research Centres, Others) – Industry Trends and Forecast to 2030.

Cell Therapy Market Analysis and Size

Cell therapy is a rapidly evolving field that involves using living cells to treat or prevent diseases. It has shown promise in various medical areas, including regenerative medicine, cancer treatment, autoimmune disorders, and more.

Data Bridge Market Research analyses that the cell therapy market which was USD 14,892 million in 2022, would rocket up to USD 60,696.42 million by 2030, and is expected to undergo a CAGR of 19.2% during the forecast period. This indicates the market value. "Cell Immortalization Technology" dominates the technology segment of the Cell Therapy market owing to the growing demand for better cell and tissue therapy methods for treatment of chronic disorders. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Cell Therapy Market Scope and Segmentation

Market Definition

Cell therapy is a type of therapy in which live cells are injected into a patient to treat several disorders. It involves the administration of somatic cell preparations for the treatment of diseases or traumatic damage. The main objective of this study is to provide long-term treatment through a single injection of therapeutic cells. For instance, T-Cells are injected for cancer treatment as they can fight cancer cells during the immunotherapy treatment course.

Global Cell Therapy Market Dynamics

Drivers

• The Rise in Prevalence and Incidence of Chronic Diseases

The majority of people around the world suffer from chronic ailments. One in three adults worldwide has a chronic illness. Chronic diseases have impacted the health and quality of life of many people. Chronic illnesses, such as cancer, musculoskeletal and neurological conditions, chronic injuries, cardiovascular and gastrointestinal conditions, and cancer, can result in hospitalization, long-term incapacity, declining quality of life, and even death.

The mesenchymal stem cells penetrate and integrate into several organs, treat lung, spinal cord, autoimmune disorders, liver, bone, and cartilage diseases, and multiple organ damage. Using stem cells in treating the inflammatory, immune system, and degenerative tissue illnesses is an effective strategy. These are certain factors that propel the growth of the market.

• The Growing Need for Potent Treatments

One of the key drivers of market expansion is significant R&D investments. In addition, the growing need for potent treatments to reduce disease burden during the forecast period is another factor fuelling the growth. For instance, the 5-year exploratory study on Parkinson's illness by Celavie Biosciences is ongoing as of May 2020. For the treatment of Parkinson's disease and other illnesses of the central nervous system, the business is developing regenerative stem cell therapies. Ok99 stem cell-based exploratory clinical studies for Parkinson's disease were effective, according to Celavie Biosciences. These are certain factors that propel the growth of the market.

Opportunities

• An Increase in R&D Activities

Additionally, the increase in R&D activities and rising investments from public and private organizations will open up new possibilities for the market's growth rate. For instance, U.S. healthcare spending increased by 3.4% in 2021, per the Health Care Price Index (HCPI). The rise in growth indicates that federal spending fell sharply the year before, from USD 287,000 million in 2020 to USD 170,000 million in 2021.

The prompt treatment of chronic illnesses has increased the demand for stem cell therapy in the U.S. and Europe. Due to these positive elements, there is a greater need for drugs, and both major and minor market players are employing various techniques to meet this demand. This factor is expected to boost market growth.

• The strategic Initiatives by Market Players

The leading companies are also working to develop targeted strategies, including product launches, acquisitions, approvals, expansions, and partnerships, to ensure the smooth operation of the business, minimize risks, and boost the market's long-term growth in sales. This factor is expected to boost the market growth.

For instance,

To create and market the search-use-only (RUO) microfluidic intracellular delivery technology, ViaCyte, Inc. teamed up with SQZ Biotechnologies in May 2022. Through the agreement, both market participants can share new cell engineering research in hematopoietic stem cells.

Restraint/Challenge

• High cost associated with the treatment

Cell therapy treatment market expansion has been hampered by its high cost. As people search for the newest therapy choices, cell treatments have emerged as a popular treatment option. Despite the enormous rise in demand for cell therapy, treatments are still exceedingly expensive. Depending on the situation, simple joint injections might cost up to $1,000, and more complex operations can cost up to $100,000. In the U.S., the average price of stem cell therapy will be between $4,000 and $8,000 per patient in 2020. Therefore, the growth of the cell therapy market is restrained by the high cost of the treatment.

This cell therapy market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Cell Therapy market contact Data Bridge Market Research for an analyst brief, our team will help you make an informed market decision to achieve market growth.

Recent Development

• In December 2021, Century Therapeutics, a biotechnology company, collaborated with Bristol Myers Squibb, a pharmaceutical company, and signed a license agreement to develop and commercialize up to four induced pluripotent stem cell ("iPSC") derived, engineered natural killer cell ("iNK") and T cell ("iT") programs for hematologic malignancies and solid tumors.

Global Cell Therapy Market Scope

The cell therapy market is segmented on the basis of technology, type, cell type, cell source, application, and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Technology

• Somatic Cell Technology
• Cell Immortalization Technology
• Viral Vector Technology
• Genome Editing Technology
• Cell Plasticity Technology
• Three-Dimensional Technology

 Type

• Autologous
• Allogeneic

Cell Type

• Stem Cell
• Non-Stem Cell

Cell Source

• iPSCs
• Bone Marrow
• Umbilical Cord Blood-Derived Cells
• Adipose Tissues
• Neural Stem Cell

Application

• Musculoskeletal
• Cardiovascular
• Gastrointestinal
• Neurological
• Oncology
• Dermatology
• Wounds & Injuries
• Ocular
• Others

End User

• Hospitals & Clinics
• Regenerative Medicine Centres
• Diagnostic & Research Centres
• Others

Global Cell Therapy Market Regional Analysis/Insights

The global cell therapy market is analysed and market size insights and trends are provided by country, technology, type, cell type, cell source, application, and end-user, as referenced above.

The countries covered in the cell therapy market report are U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa.

North America dominates the cell therapy market because of its strong base of healthcare facilities, the strong presence of major players, the extraordinary healthcare infrastructure, and the large pool of people suffering from chronic disorders.

Asia-Pacific is expected to witness significant growth during the forecast period of 2023 to 2030 due to the increase in government initiatives to promote healthcare, the rising health awareness among the people and growing demand for advanced medical technology for chronic ailment treatments, the large population pool, and the growing demand for quality healthcare in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends, and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The cell therapy market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the Cell Therapy market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the cell therapy market.

Competitive Landscape and Cell Therapy Market Share Analysis

The cell therapy market competitive landscape provides details by competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width, and breadth, application dominance. The above data points provided are only related to the companies' focus related to the market.

Some of the major players operating in the cell therapy market are:

• Vericel Corporation (U.S)
• Kolon TissueGene Inc. (U.S)
• JCR Pharmaceuticals Co. Ltd. (Japan)
• MEDIPOST (South Korea)
• Osiris (U.S)
• Stemedica Cell Technologies Inc. (U.S)
• NuVasive Inc. (U.S)
• Fibrocell Science Inc. (U.S)
• Cellectis (France)
• BioNTech IMFS (Germany)
• Pluristem (Israel)
• Praxis Pharmaceutical (U.S)
• Genzyme Corporation (U.S)
• Advanced Tissue (U.S)
• Cells for Cells (Chile)
• PHARMICELL Co. Ltd (South Korea)
• ANTEROGEN.CO.LTD. (South Korea)
• Novartis AG (Switzerland)
• GlaxoSmithKline plc (U.K)
• CELGENE CORPORATION (U.S)
• Bone Therapeutics (Belgium)
• Cell Therapies (U.K)
• Celyad (Belgium)
• Regen BioPharma (U.S)
• Cellular Therapeutics Ltd (China)
• TxCell (France)
• Advancells (India)